Search Results - "Pan, Hongchao"
-
1
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Published in The New England journal of medicine (09-11-2017)“…In a meta-analysis of 88 trials involving nearly 63,000 women with breast cancer who were disease-free after 5 years of endocrine therapy, the risk of…”
Get full text
Journal Article -
2
Expression and function of chondroitin 4‐sulfate and chondroitin 6‐sulfate in human glioma
Published in The FASEB journal (01-02-2020)“…Key molecules promoting migration and invasion exist in the extracellular matrix, and include chondroitin 4‐sulfate (C4S) and chondroitin 6‐sulfate (C6S),…”
Get full text
Journal Article -
3
Considerations in boosting COVID-19 vaccine immune responses
Published in The Lancet (British edition) (09-10-2021)“…A new wave of COVID-19 cases caused by the highly transmissible delta variant is exacerbating the worldwide public health crisis, and has led to consideration…”
Get full text
Journal Article -
4
Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression
Published in Cell death & disease (07-08-2021)“…The PD-L1 overexpression is an important event of immune escape and metastasis in triple-negative breast cancer (TNBC), but the molecular mechanism remains to…”
Get full text
Journal Article -
5
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
Published in JNCI : Journal of the National Cancer Institute (01-07-2021)“…Abstract Ki67 immunohistochemistry (IHC), commonly used as a proliferation marker in breast cancer, has limited value for treatment decisions due to…”
Get full text
Journal Article -
6
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Published in The Lancet (British edition) (09-03-2013)“…Summary Background For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamoxifen for 5 years substantially reduces the breast…”
Get full text
Journal Article -
7
ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway
Published in Cell death & disease (02-11-2021)“…Advanced breast cancer (BC), especially basal like triple-negative BC (TNBC), is a highly malignant tumor without viable treatment option, highlighting the…”
Get full text
Journal Article -
8
ARSD is responsible for carcinoma and amyloidosis of breast epithelial cells
Published in European journal of cell biology (01-04-2022)“…Breast cancer (BC) and Alzheimer's disease (AD) have pronounced female-to-male disparities and both are the major causes of death in elderly women…”
Get full text
Journal Article -
9
Avoiding 40% of the premature deaths in each country, 2010–30: review of national mortality trends to help quantify the UN Sustainable Development Goal for health
Published in The Lancet (British edition) (17-01-2015)“…Summary Background The UN will formulate ambitious Sustainable Development Goals for 2030, including one for health. Feasible goals with some quantifiable,…”
Get full text
Journal Article -
10
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial
Published in The Lancet (British edition) (25-09-2010)“…Summary Background If carotid artery narrowing remains asymptomatic (ie, has caused no recent stroke or other neurological symptoms), successful carotid…”
Get full text
Journal Article -
11
Trimebutine, a small molecule mimetic agonist of adhesion molecule L1, contributes to functional recovery after spinal cord injury in mice
Published in Disease models & mechanisms (01-09-2017)“…Curing spinal cord injury (SCI) in mammals is a daunting task because of the lack of permissive mechanisms and strong inhibitory responses at and around the…”
Get full text
Journal Article -
12
Everestmab, a novel long-acting GLP-1/anti GLP-1R nanobody fusion protein, exerts potent anti-diabetic effects
Published in Artificial cells, nanomedicine, and biotechnology (01-01-2020)“…In the present study, a novel single domain antibody (sdAb) fusion protein, named everestmab, composing of a mutated GLP-1(A8G) fused to the tandem bispecific…”
Get full text
Journal Article -
13
Risk of Stroke From New Carotid Artery Occlusion in the Asymptomatic Carotid Surgery Trial-1
Published in Stroke (1970) (01-06-2013)“…In the Asymptomatic Carotid Surgery Trial-1 (ACST-1), 3120 patients with tight asymptomatic carotid stenosis were randomly assigned to medical treatment alone…”
Get full text
Journal Article -
14
Relationship between Chromosome 18q Status and Colorectal Cancer Prognosis: A Prospective, Blinded Analysis of 280 Patients
Published in Anticancer research (01-01-2007)“…Background: The relationship between chromosome 18q allelic imbalance (AI) and survival in colorectal cancer (CRC) is unclear, and study design may have…”
Get full text
Journal Article -
15
Tobacco smoking and the risk of Parkinson disease: A 65-year follow-up of 30,000 male British doctors
Published in Neurology (19-05-2020)“…OBJECTIVETo investigate the causal relevance of current tobacco smoking for the risk of Parkinson disease (PD). METHODSWe compared the risks of death from PD…”
Get full text
Journal Article -
16
A Novel Immune-Related Signature to Predict Prognosis and Immune Infiltration of Cervical Cancer
Published in Medical science monitor (28-03-2023)“…BACKGROUND Cervical cancer is one of the most common malignances among women globally. This study aimed to construct a novel immune-related signature to…”
Get full text
Journal Article -
17
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Published in The Lancet (British edition) (21-05-2022)“…The Solidarity trial among COVID-19 inpatients has previously reported interim mortality analyses for four repurposed antiviral drugs. Lopinavir,…”
Get full text
Journal Article -
18
10 vs 5 years of adjuvant tamoxifen: exclusion of 1/402 centres in ATLAS
Published in The Lancet (British edition) (13-05-2017)“…ATLAS is an international trial of the main effects of prolonging adjuvant tamoxifen. It involves 15 000 women with early breast cancer, randomised in…”
Get full text
Journal Article -
19
Forkhead box C1 boosts triple‐negative breast cancer metastasis through activating the transcription of chemokine receptor‐4
Published in Cancer science (01-12-2018)“…The transcription factor forkhead box C1 (FOXC1) has recently been proposed as a crucial regulator of triple‐negative breast cancer (TNBC) and associated with…”
Get full text
Journal Article -
20
Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression
Published in Breast cancer research and treatment (01-04-2024)“…Purpose The potential of targeting forkhead box C1 (FOXC1) as a therapeutic approach for triple-negative breast cancer (TNBC) is promising. However, a…”
Get full text
Journal Article